Lv3
340 积分 2024-11-25 加入
A RANDOMIZED, DOUBLE-BLIND COMPARATIVE TRIAL EVALUATING THE SAFETY OF LIPOSOMAL AMPHOTERICIN B VERSUS AMPHOTERICIN B LIPID COMPLEX IN THE EMPIRICAL TREATMENT OF FEBRILE NEUTROPENIA
3天前
已完结
Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study
3天前
已完结
Application of Physiologically Based Pharmacokinetic Model to Compare the Biodistribution of Liposomal Amphotericin B With Conventional Amphotericin B Deoxycholate in Humans
4天前
已完结
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12)
1个月前
已完结
Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections
1个月前
已完结
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China
1个月前
已完结
Ceftolozane/Tazobactam: A Novel Cephalosporin/β‐Lactamase Inhibitor Combination
1个月前
已完结
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
1个月前
已完结
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
1个月前
已完结
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
1个月前
已完结
皖公网安备34019202002308
